Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Oxalo Therapeutics
company
About
Oxalo Therapeutics is a Biotechnology Company.
- 1 - 10
Details
- Last Funding Type
- Grant
- Last Funding Money Raised
- $2.30M
- Industries
- Biotechnology,Clinical Trials,Medical,Therapeutics
- Founded date
- Jan 1, 2017
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$3.52M
Oxalo Therapeutics has raised a total of
$3.52M
in funding over 2 rounds. Their latest funding was raised on
Apr 15, 2022 from a Grant round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Apr 15, 2022 | Grant | $0.99M | 1 |
National Science Foundation
|
— | Detail |
| Jun 28, 2019 | Grant | $224.99K | 1 |
National Science Foundation
|
— | Detail |
| Sep 24, 2018 | Grant | $2.30M | 1 |
National Institutes of Health
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
3
2
Oxalo Therapeutics is funded by 2 investors.
National Science Foundation
and National Institutes of Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
National Science Foundation
|
Yes | Grant |
|
National Institutes of Health
|
Yes | Grant |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
